Ian J. Nicholson
InvestorOperating Partner at Advent Life Sciences
About
Ian J. Nicholson joined Advent in 2012 after an international career in life sciences. He currently serves as Chief Business Officer of Eloxx Pharmaceuticals and previously was CEO of F2G Limited, an antifungal company; earlier roles included Senior Vice President of Business Development at Celltech Group plc and senior commercial positions at Chroma Therapeutics, Oxford Asymmetry International, Lonza AG and Amersham International. He holds a B.Sc. (Hons.) from University College London and an MBA from Boston University.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
Bioventix plc
Per the firm's website.
Colleagues at Advent Life Sciences
Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Andrea Beesley
Team Assistant at Advent Life Sciences
Bonita Theara
Executive Assistant at Advent Life Sciences
Dominic Schmidt
General Partner at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Fraser Murray
Head of Scientific Evaluation at Advent Life Sciences
Gail Jermyn
Investor Relations Partner at Advent Life Sciences
Frequently asked questions
- Who is Ian J. Nicholson?
- Ian J. Nicholson joined Advent in 2012 after an international career in life sciences. He currently serves as Chief Business Officer of Eloxx Pharmaceuticals and previously was CEO of F2G Limited, an antifungal company; earlier roles included Senior Vice President of Business Development at Celltech Group plc and senior commercial positions at Chroma Therapeutics, Oxford Asymmetry International, Lonza AG and Amersham International. He holds a B.Sc. (Hons.) from University College London and an MBA from Boston University.
- Where does Ian J. Nicholson work?
- Ian J. Nicholson is Operating Partner at Advent Life Sciences.
- What does Ian J. Nicholson invest in?
- Ian J. Nicholson invests in Biotech.
- What boards does Ian J. Nicholson sit on?
- Ian J. Nicholson holds tracked board seats at Bioventix plc.